Emotional Intelligence Ventures

Emotional Intelligence Ventures, a company looking to develop a botanical approach to psychedelic medicines, announced that its Reg A has reached a milestone of $20 million. The Hawaii-based company announced a $50 million public stock offering using the Reg A+ Framework in March. This type of...

MindMed Posts 2020 Financials, New MDMA Dosing Study and 18-MC Patent Application MindMed (OTCQB:MMEDF) released its full-year 2020 financial results.  The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the...

Emotional Intelligence Ventures, a company dedicated to research and production of botanical psychedelics, announced a public stock offering using the Reg A+ Framework. The company received qualification from the Securities and Exchange Commission to launch a Regulation A+ Tier 2 offering, which...